LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article ; Online: The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers.

    Cloutier, Maryse / Fortin, Jean-Simon / Thibodeau, Jacques

    BMC immunology

    2021  Volume 22, Issue 1, Page(s) 56

    Abstract: Background: Invariant chain (CD74, Ii) is a multifunctional protein expressed in antigen presenting cells. It assists the ER exit of various cargos and serves as a receptor for the macrophage migration inhibitory factor. The newly translated Ii chains ... ...

    Abstract Background: Invariant chain (CD74, Ii) is a multifunctional protein expressed in antigen presenting cells. It assists the ER exit of various cargos and serves as a receptor for the macrophage migration inhibitory factor. The newly translated Ii chains trimerize, a structural feature that is not readily understood in the context of its MHCII chaperoning function. Two segments of Ii, the luminal C-terminal region (TRIM) and the transmembrane domain (TM), have been shown to participate in the trimerization process but their relative importance and impact on the assembly with MHCII molecules remains debated. Here, we addressed the requirement of these domains in the trimerization of human Ii as well as in the oligomerization with MHCII molecules. We used site-directed mutagenesis to generate series of Ii and DR mutants. These were transiently transfected in HEK293T cells to test their cell surface expression and analyse their interactions by co-immunoprecipitations.
    Results: Our results showed that the TRIM domain is not essential for Ii trimerization nor for intracellular trafficking with MHCII molecules. We also gathered evidence that in the absence of TM, TRIM allows the formation of multi-subunit complexes with HLA-DR. Similarly, in the absence of TRIM, Ii can assemble into high-order structures with MHCII molecules.
    Conclusions: Altogether, our data show that trimerization of Ii through either TM or TRIM sustains nonameric complex formation with MHCII molecules.
    MeSH term(s) Antigen Presentation ; Antigens, Differentiation, B-Lymphocyte/genetics ; Antigens, Differentiation, B-Lymphocyte/metabolism ; Cell Membrane/metabolism ; HEK293 Cells ; HLA-A24 Antigen/metabolism ; HLA-DR Antigens/genetics ; Histocompatibility Antigens Class II/genetics ; Histocompatibility Antigens Class II/metabolism ; Humans ; Mutagenesis, Site-Directed ; Mutation/genetics ; Protein Domains/genetics ; Protein Multimerization
    Chemical Substances Antigens, Differentiation, B-Lymphocyte ; HLA-A*24:02 antigen ; HLA-A24 Antigen ; HLA-DR Antigens ; Histocompatibility Antigens Class II ; invariant chain
    Language English
    Publishing date 2021-08-12
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2041500-X
    ISSN 1471-2172 ; 1471-2172
    ISSN (online) 1471-2172
    ISSN 1471-2172
    DOI 10.1186/s12865-021-00444-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy.

    Shukla, Akhil / Cloutier, Maryse / Appiya Santharam, Madanraj / Ramanathan, Sheela / Ilangumaran, Subburaj

    International journal of molecular sciences

    2021  Volume 22, Issue 4

    Abstract: The immune system constantly monitors the emergence of cancerous cells and eliminates them. ... ...

    Abstract The immune system constantly monitors the emergence of cancerous cells and eliminates them. CD8
    MeSH term(s) Animals ; Antigens, Neoplasm/metabolism ; Genes, MHC Class I ; Humans ; Immunotherapy ; Intracellular Signaling Peptides and Proteins/metabolism ; Neoplasms/immunology ; Neoplasms/therapy ; Trans-Activators/metabolism
    Chemical Substances Antigens, Neoplasm ; Intracellular Signaling Peptides and Proteins ; Trans-Activators
    Language English
    Publishing date 2021-02-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22041964
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The GIMAP Family Proteins: An Incomplete Puzzle.

    Limoges, Marc-André / Cloutier, Maryse / Nandi, Madhuparna / Ilangumaran, Subburaj / Ramanathan, Sheela

    Frontiers in immunology

    2021  Volume 12, Page(s) 679739

    Abstract: ... ...

    Abstract Overview
    MeSH term(s) Animals ; B-Lymphocytes/immunology ; B-Lymphocytes/metabolism ; Disease Susceptibility ; GTP-Binding Proteins/chemistry ; GTP-Binding Proteins/genetics ; GTP-Binding Proteins/metabolism ; Gene Expression Regulation ; Hematopoietic Stem Cells ; Humans ; Membrane Proteins/chemistry ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Multigene Family ; Mutation ; Signal Transduction ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism
    Chemical Substances Membrane Proteins ; GTP-Binding Proteins (EC 3.6.1.-)
    Language English
    Publishing date 2021-05-31
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.679739
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Application of EdU-Based DNA Synthesis Assay to Measure Hepatocyte Proliferation In Situ During Liver Regeneration.

    Ghosh, Amit / Ihsan, Awais Ullah / Nandi, Madhuparna / Cloutier, Maryse / Khan, Md Gulam Musawwir / Ramanathan, Sheela / Ilangumaran, Subburaj

    Methods in molecular biology (Clifton, N.J.)

    2022  Volume 2544, Page(s) 195–206

    Abstract: Monitoring hepatocyte proliferation in situ following partial hepatectomy is widely used to characterize cytokines, growth factors and signaling molecules and pathways as well as the regulatory mechanisms involved in liver regeneration. Periodic ... ...

    Abstract Monitoring hepatocyte proliferation in situ following partial hepatectomy is widely used to characterize cytokines, growth factors and signaling molecules and pathways as well as the regulatory mechanisms involved in liver regeneration. Periodic measurement of the liver/body mass ratio estimates the rate of liver regeneration, which is often supplemented by evaluating the proportion of proliferating hepatocytes using a synthetic nucleoside analog such as 5-bromo-2'-deoxyuridine (BrdU) or the nuclear accumulation of proliferating cell nuclear antigen (PCNA) in proliferating cells. The introduction of the thymidine analog 5-ethynyl-2'deoxyuridine (EdU) and its detection by "click chemistry" using fluorescently labeled reagents has simplified the evaluation of live cell proliferation as it eliminates certain limitations of antibody-mediated detection of BrdU. Here, we describe the EdU-based measurement of hepatocyte proliferation during liver regeneration and correlate the results with that of Ki67 and PCNA-based assays.
    MeSH term(s) Bromodeoxyuridine/metabolism ; Cell Proliferation ; Cytokines ; DNA/metabolism ; Hepatocytes/metabolism ; Ki-67 Antigen ; Liver Regeneration ; Nucleosides ; Proliferating Cell Nuclear Antigen ; Thymidine
    Chemical Substances Cytokines ; Ki-67 Antigen ; Nucleosides ; Proliferating Cell Nuclear Antigen ; DNA (9007-49-2) ; Bromodeoxyuridine (G34N38R2N1) ; Thymidine (VC2W18DGKR)
    Language English
    Publishing date 2022-09-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-2557-6_14
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The MHC Class-I Transactivator NLRC5

    Akhil Shukla / Maryse Cloutier / Madanraj Appiya Santharam / Sheela Ramanathan / Subburaj Ilangumaran

    International Journal of Molecular Sciences, Vol 22, Iss 4, p

    Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy

    2021  Volume 1964

    Abstract: The immune system constantly monitors the emergence of cancerous cells and eliminates them. CD8 + cytotoxic T lymphocytes (CTLs), which kill tumor cells and provide antitumor immunity, select their targets by recognizing tumor antigenic peptides ... ...

    Abstract The immune system constantly monitors the emergence of cancerous cells and eliminates them. CD8 + cytotoxic T lymphocytes (CTLs), which kill tumor cells and provide antitumor immunity, select their targets by recognizing tumor antigenic peptides presented by MHC class-I (MHC-I) molecules. Cancer cells circumvent immune surveillance using diverse strategies. A key mechanism of cancer immune evasion is downregulation of MHC-I and key proteins of the antigen processing and presentation machinery (APM). Even though impaired MHC-I expression in cancers is well-known, reversing the MHC-I defects remains the least advanced area of tumor immunology. The discoveries that NLRC5 is the key transcriptional activator of MHC-I and APM genes, and genetic lesions and epigenetic modifications of NLRC5 are the most common cause of MHC-I defects in cancers, have raised the hopes for restoring MHC-I expression. Here, we provide an overview of cancer immunity mediated by CD8 + T cells and the functions of NLRC5 in MHC-I antigen presentation pathways. We describe the impressive advances made in understanding the regulation of NLRC5 expression, the data supporting the antitumor functions of NLRC5 and a few reports that argue for a pro-tumorigenic role. Finally, we explore the possible avenues of exploiting NLRC5 for cancer immunotherapy.
    Keywords NLRC5 ; MHC-I ; cancer immunotherapy ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 570
    Language English
    Publishing date 2021-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis.

    Cloutier, Maryse / Nandi, Madhuparna / Ihsan, Awais Ullah / Chamard, Hugues Allard / Ilangumaran, Subburaj / Ramanathan, Sheela

    Cytokine

    2020  Volume 136, Page(s) 155256

    Abstract: The COVID-19 pandemic has rapidly spread around the world with significant morbidity and mortality in a subset of patients including the elderly. The poorer outcomes are associated with 'cytokine storm-like' immune responses, otherwise referred to as ' ... ...

    Abstract The COVID-19 pandemic has rapidly spread around the world with significant morbidity and mortality in a subset of patients including the elderly. The poorer outcomes are associated with 'cytokine storm-like' immune responses, otherwise referred to as 'hyperinflammation'. While most of the infected individuals show minimal or no symptoms and recover spontaneously, a small proportion of the patients exhibit severe symptoms characterized by extreme dyspnea and low tissue oxygen levels, with extensive damage to the lungs referred to as acute respiratory distress symptom (ARDS). The consensus is that the hyperinflammatory response of the host is akin to the cytokine storm observed during sepsis and is the major cause of death. Uncertainties remain on the factors that lead to hyperinflammatory response in some but not all individuals. Hyperinflammation is a common feature in different viral infections such as dengue where existing low-titer antibodies to the virus enhances the infection in immune cells through a process called antibody-dependent enhancement or ADE. ADE has been reported following vaccination or secondary infections with other corona, Ebola and dengue virus. Detailed analysis has shown that antibodies to any viral epitope can induce ADE when present in sub-optimal titers or is of low affinity. In this review we will discuss ADE in the context of dengue and coronavirus infections including Covid-19.
    MeSH term(s) Animals ; Antibody-Dependent Enhancement/immunology ; COVID-19 ; Cats ; Coronavirus Infections/immunology ; Coronavirus Infections/veterinary ; Cytokines/metabolism ; Feline Infectious Peritonitis/immunology ; Inflammation/pathology ; Pandemics/veterinary ; Pneumonia, Viral/immunology ; Pneumonia, Viral/veterinary ; Severe Dengue/immunology
    Chemical Substances Cytokines
    Keywords covid19
    Language English
    Publishing date 2020-08-20
    Publishing country England
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1018055-2
    ISSN 1096-0023 ; 1043-4666
    ISSN (online) 1096-0023
    ISSN 1043-4666
    DOI 10.1016/j.cyto.2020.155256
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis.

    Quenum, Akouavi Julite I / Shukla, Akhil / Rexhepi, Fjolla / Cloutier, Maryse / Ghosh, Amit / Kufer, Thomas A / Ramanathan, Sheela / Ilangumaran, Subburaj

    Frontiers in immunology

    2021  Volume 12, Page(s) 749646

    Abstract: The nucleotide-binding leucine-rich repeat-containing receptor (NLR) family protein-5 (NLRC5) controls NF-κB activation and production of inflammatory cytokines in certain cell types. NLRC5 is considered a potential regulator of hepatic fibrogenic ... ...

    Abstract The nucleotide-binding leucine-rich repeat-containing receptor (NLR) family protein-5 (NLRC5) controls NF-κB activation and production of inflammatory cytokines in certain cell types. NLRC5 is considered a potential regulator of hepatic fibrogenic response due to its ability to inhibit hepatic stellate activation
    MeSH term(s) Alanine Transaminase/blood ; Animals ; Carbon Tetrachloride ; Cytokines/blood ; Cytokines/genetics ; Cytokines/immunology ; Gene Expression ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/immunology ; Liver/immunology ; Liver/pathology ; Liver Cirrhosis/blood ; Liver Cirrhosis/genetics ; Liver Cirrhosis/immunology ; Liver Cirrhosis/pathology ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Transcription Factor RelA/immunology ; Mice
    Chemical Substances Cytokines ; Intracellular Signaling Peptides and Proteins ; NLRC5 protein, mouse ; Transcription Factor RelA ; Carbon Tetrachloride (CL2T97X0V0) ; Alanine Transaminase (EC 2.6.1.2)
    Language English
    Publishing date 2021-10-12
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.749646
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: SILAC proteomics implicates SOCS1 in modulating cellular macromolecular complexes and the ubiquitin conjugating enzyme UBE2D involved in MET receptor tyrosine kinase downregulation.

    Santharam, Madanraj Appiya / Shukla, Akhil / Ihsan, Awais Ullah / Cloutier, Maryse / Levesque, Dominique / Ramanathan, Sheela / Boisvert, François-Michel / Ilangumaran, Subburaj

    Biochimie

    2021  Volume 182, Page(s) 185–196

    Abstract: Suppressor of Cytokine Signaling 1 (SOCS1) functions as a tumor suppressor in hepatocellular carcinoma and many other types of cancers. SOCS1 mediates its functions by inhibiting tyrosine kinases, promoting ubiquitination and proteasomal degradation of ... ...

    Abstract Suppressor of Cytokine Signaling 1 (SOCS1) functions as a tumor suppressor in hepatocellular carcinoma and many other types of cancers. SOCS1 mediates its functions by inhibiting tyrosine kinases, promoting ubiquitination and proteasomal degradation of signal transducing proteins, and by modulating transcription factors. Here, we studied the impact of SOCS1 on the hepatocyte proteome using Stable Isotopic Labelling of Amino acids in Cell culture (SILAC)-based mass spectrometry on the Hepa1-6 murine HCC cell line stably expressing wildtype SOCS1 or a mutant SOCS1 with impaired SH2 domain. As SOCS1 regulates the hepatocyte growth factor (HGF) receptor, the MET receptor tyrosine kinase (RTK), the SILAC-labelled cells were stimulated or not with HGF. Following mass spectrometry analysis, differentially modulated proteins were identified, quantified and analyzed for pathway enrichment. Of the 3440 proteins identified in Hepa-SOCS1 cells at steady state, 181 proteins were significantly modulated compared to control cells. The SH2 domain mutation and HGF increased the number of differentially modulated proteins. Protein interaction network analysis revealed enrichment of SOCS1-modulated proteins within multiprotein complexes such as ubiquitin conjugating enzymes, proteasome, mRNA spliceosome, mRNA exosome and mitochondrial ribosome. Notably, the expression of UBE2D ubiquitin conjugating enzyme, which is implicated in the control of growth factor receptor tyrosine kinase signaling, was found to be regulated by SOCS1. These findings suggest that SOCS1, induced by cytokines, growth factors and diverse other stimuli, has the potential to dynamically modulate of large macromolecular regulatory complexes to help maintain cellular homeostasis.
    MeSH term(s) Animals ; Cell Line ; Down-Regulation ; Gene Expression Regulation, Enzymologic ; Mice ; Proteomics ; Proto-Oncogene Proteins c-met/biosynthesis ; Proto-Oncogene Proteins c-met/genetics ; Suppressor of Cytokine Signaling 1 Protein/genetics ; Suppressor of Cytokine Signaling 1 Protein/metabolism ; Ubiquitin-Conjugating Enzymes/genetics ; Ubiquitin-Conjugating Enzymes/metabolism ; src Homology Domains
    Chemical Substances Socs1 protein, mouse ; Suppressor of Cytokine Signaling 1 Protein ; Ubiquitin-Conjugating Enzymes (EC 2.3.2.23) ; Proto-Oncogene Proteins c-met (EC 2.7.10.1)
    Language English
    Publishing date 2021-01-23
    Publishing country France
    Document type Journal Article
    ZDB-ID 120345-9
    ISSN 1638-6183 ; 0300-9084
    ISSN (online) 1638-6183
    ISSN 0300-9084
    DOI 10.1016/j.biochi.2021.01.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis

    Cloutier, Maryse / Nandi, Madhuparna / Ihsan, Awais Ullah / Chamard, Hugues Allard / Ilangumaran, Subburaj / Ramanathan, Sheela

    Cytokine

    2020  Volume 136, Page(s) 155256

    Keywords Immunology ; Immunology and Allergy ; Biochemistry ; Molecular Biology ; Hematology ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1018055-2
    ISSN 1096-0023 ; 1043-4666
    ISSN (online) 1096-0023
    ISSN 1043-4666
    DOI 10.1016/j.cyto.2020.155256
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article: ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis

    Cloutier, Maryse / Nandi, Madhuparna / Ihsan, Awais Ullah / Chamard, Hugues Allard / Ilangumaran, Subburaj / Ramanathan, Sheela

    Cytokine

    Abstract: The COVID-19 pandemic has rapidly spread around the world with significant morbidity and mortality in a subset of patients including the elderly. The poorer outcomes are associated with 'cytokine storm-like' immune responses, otherwise referred to as ' ... ...

    Abstract The COVID-19 pandemic has rapidly spread around the world with significant morbidity and mortality in a subset of patients including the elderly. The poorer outcomes are associated with 'cytokine storm-like' immune responses, otherwise referred to as 'hyperinflammation'. While most of the infected individuals show minimal or no symptoms and recover spontaneously, a small proportion of the patients exhibit severe symptoms characterized by extreme dyspnea and low tissue oxygen levels, with extensive damage to the lungs referred to as acute respiratory distress symptom (ARDS). The consensus is that the hyperinflammatory response of the host is akin to the cytokine storm observed during sepsis and is the major cause of death. Uncertainties remain on the factors that lead to hyperinflammatory response in some but not all individuals. Hyperinflammation is a common feature in different viral infections such as dengue where existing low-titer antibodies to the virus enhances the infection in immune cells through a process called antibody-dependent enhancement or ADE. ADE has been reported following vaccination or secondary infections with other corona, Ebola and dengue virus. Detailed analysis has shown that antibodies to any viral epitope can induce ADE when present in sub-optimal titers or is of low affinity. In this review we will discuss ADE in the context of dengue and coronavirus infections including Covid-19.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #722276
    Database COVID19

    Kategorien

To top